BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Constellation Pharmaceuticals 

215 First St, Suite 200

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-714-0555 Fax: 617-859-2891


SEARCH JOBS





 Key Statistics


Email:
Ownership: Private

Web Site: Constellation Pharmaceuticals
Employees:
Symbol: 
 




Segment
Start Up





 Company News
Constellation Pharmaceuticals and the University of Pittsburgh School of Medicine Receive Cystic Fibrosis Foundation Research Grant 10/10/2013 9:36:10 AM
Constellation Pharmaceuticals Announces New Preclinical Data on Novel BET Bromodomain Inhibitors Published in The Journal of Experimental Medicine 10/8/2013 10:38:19 AM
Constellation Pharmaceuticals Initiates Clinical Development of CPI-0610, a Novel BET Protein Bromodomain Inhibitor, in Patients With Lymphoma 9/10/2013 9:32:50 AM
Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies 9/20/2012 10:22:54 AM
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer 3/27/2012 6:52:54 AM
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms 1/17/2012 6:55:55 AM
Constellation Pharmaceuticals Raises $15 Million in Additional Funding 6/6/2011 6:34:59 AM
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans 2/1/2011 8:44:14 AM
Constellation Pharmaceuticals Appoints Industry Veteran James E. Audia, Ph.D. as Chief Scientific Officer 1/4/2011 8:58:18 AM
Constellation Pharmaceuticals Closes $22 Million in Series B Funding 6/2/2010 6:32:11 AM
12